Max Beijert

1.2k total citations
17 papers, 283 citations indexed

About

Max Beijert is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Max Beijert has authored 17 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Max Beijert's work include Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (5 papers) and Advanced Radiotherapy Techniques (4 papers). Max Beijert is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (5 papers) and Advanced Radiotherapy Techniques (4 papers). Max Beijert collaborates with scholars based in Netherlands, Australia and Denmark. Max Beijert's co-authors include Jeanette K. Doorduijn, Jacoline E. C. Bromberg, Marcel Nijland, Gavin Cull, Katerina Bakunina, Marc Durian, Kylie D. Mason, Harry C. Schouten, Wendy B.C. Stevens and Tatjana Seute and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Max Beijert

17 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Beijert Netherlands 7 194 181 137 72 41 17 283
Alessia Castellino Italy 11 279 1.4× 143 0.8× 102 0.7× 180 2.5× 30 0.7× 34 356
Jackline de Paula Ayres-Silva Brazil 7 173 0.9× 124 0.7× 145 1.1× 48 0.7× 40 1.0× 13 291
Sylvie Glaisner France 8 188 1.0× 118 0.7× 124 0.9× 100 1.4× 36 0.9× 17 330
Hanne Kuitunen Finland 12 270 1.4× 92 0.5× 157 1.1× 168 2.3× 72 1.8× 45 380
Lucille Baseggio France 4 276 1.4× 75 0.4× 169 1.2× 137 1.9× 34 0.8× 9 315
Antonello Calderoni Switzerland 7 194 1.0× 210 1.2× 134 1.0× 82 1.1× 23 0.6× 12 327
Katerina Bakunina Netherlands 9 242 1.2× 239 1.3× 209 1.5× 65 0.9× 81 2.0× 18 366
Vít Campr Czechia 10 210 1.1× 67 0.4× 121 0.9× 147 2.0× 81 2.0× 46 328
Diana Libster Israel 9 188 1.0× 58 0.3× 70 0.5× 115 1.6× 78 1.9× 16 301
Rita Mazza Italy 12 216 1.1× 109 0.6× 71 0.5× 178 2.5× 64 1.6× 22 298

Countries citing papers authored by Max Beijert

Since Specialization
Citations

This map shows the geographic impact of Max Beijert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Beijert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Beijert more than expected).

Fields of papers citing papers by Max Beijert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Beijert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Beijert. The network helps show where Max Beijert may publish in the future.

Co-authorship network of co-authors of Max Beijert

This figure shows the co-authorship network connecting the top 25 collaborators of Max Beijert. A scholar is included among the top collaborators of Max Beijert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Beijert. Max Beijert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Aleman, Berthe M.P., Umberto Ricardi, Richard W.M. van der Maazen, et al.. (2023). A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned. International Journal of Radiation Oncology*Biology*Physics. 117(3). 664–674. 3 indexed citations
2.
Doesum, Jaap A. van, Max Beijert, Marcel Nijland, et al.. (2021). Radiotherapy Is an Excellent Bridging Strategy in Large B-Cell Lymphoma Patients Selected for CAR T-Cell Therapy. Blood. 138(Supplement 1). 2510–2510. 3 indexed citations
3.
Meulen, Matthijs van der, Linda Dirven, Esther J. J. Habets, et al.. (2021). Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trial. Neuro-Oncology. 23(8). 1315–1326. 9 indexed citations
4.
Beijert, Max, Jaap A. van Doesum, Johannes A. Langendijk, et al.. (2021). OC-0206 Radiotherapy as bridging strategy in Large B-cell lymphoma patients selected for CAR T-cell therapy. Radiotherapy and Oncology. 161. S137–S138. 1 indexed citations
5.
Aleman, Berthe M.P., Cécile P.M. Janus, Saskia E. Rademakers, et al.. (2021). Anthracycline exposure and breast cancer risk in female Hodgkin lymphoma survivors.. Journal of Clinical Oncology. 39(15_suppl). 12074–12074. 2 indexed citations
6.
Doesum, Jaap A. van, et al.. (2021). Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment. HemaSphere. 5(2). e523–e523. 19 indexed citations
7.
Meulen, Matthijs van der, Katerina Bakunina, Marcel Nijland, et al.. (2020). Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study. Annals of Oncology. 31(8). 1046–1055. 4 indexed citations
8.
Bromberg, Jacoline E. C., Samar Issa, Katerina Bakunina, et al.. (2019). Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study. The Lancet Oncology. 20(2). 216–228. 162 indexed citations
9.
Aleman, Berthe M.P., Umberto Ricardi, Paul Meijnders, et al.. (2019). PRELIMINARY RESULTS OF A QUALITY CONTROL STUDY ON INVOLVED NODE RADIOTHERAPY IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA. Hematological Oncology. 37(S2). 487–488. 2 indexed citations
10.
Schaapveld, Michael, Cécile P.M. Janus, Augustinus D. G. Krol, et al.. (2018). Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer. Cancer Medicine. 8(1). 190–199. 5 indexed citations
11.
Aznar, Marianne, T. Girinsky, Anne Kiil Berthelsen, et al.. (2017). Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group. Acta Oncologica. 56(4). 608–613. 9 indexed citations
12.
Veeger, Nic J.G.M., Francisca Ong, Wilma G.J.M. Smit, et al.. (2016). Progression of a solitary plasmacytoma to multiple myeloma. A population‐based registry of the northern Netherlands. British Journal of Haematology. 175(4). 661–667. 40 indexed citations
13.
Ubbels, Jan F., Max Beijert, Harry J.M. Groen, et al.. (2015). An instrument dedicated for modelling of pulmonary radiotherapy. Radiotherapy and Oncology. 115(1). 3–8. 8 indexed citations
14.
Schaapveld, Michael, Anna M. van Eggermond, Cécile P.M. Janus, et al.. (2014). Cause-specific mortality among patients with Hodgkin lymphoma (HL) up to 40 years after treatment.. Journal of Clinical Oncology. 32(15_suppl). 9517–9517. 2 indexed citations
15.
Krijgsman, Oscar, Margaretha G.M. Roemer, Stefanie Slot, et al.. (2013). Dissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features. Haematologica. 98(12). 1921–1929. 6 indexed citations
16.
Brouwer, Charlotte L., et al.. (2012). Scrotal Irradiation in Primary Testicular Lymphoma: Review of the Literature and In Silico Planning Comparative Study. International Journal of Radiation Oncology*Biology*Physics. 85(2). 298–308. 7 indexed citations
17.
Aleman, Berthe M.P., et al.. (2012). Second Cancer Risk 40 Years After Hodgkin Lymphoma Treatment. International Journal of Radiation Oncology*Biology*Physics. 84(3). S70–S71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessia Castellino Breakdown of academic impact, for papers by Jackline de Paula Ayres-Silva Breakdown of academic impact, for papers by Sylvie Glaisner Breakdown of academic impact, for papers by Hanne Kuitunen Breakdown of academic impact, for papers by Lucille Baseggio Breakdown of academic impact, for papers by Antonello Calderoni Breakdown of academic impact, for papers by Katerina Bakunina Breakdown of academic impact, for papers by Vít Campr Breakdown of academic impact, for papers by Diana Libster Breakdown of academic impact, for papers by Rita Mazza
Rankless by CCL
2026